Risk Intelligence
Sustained high fatty alcohol prices
View Risks →Galaxy Surfactants reported Q3 FY26 EBITDA of ₹124 crore, up 13% YoY, driven by strong specialty volume growth in India (+35%) and rest-of-world markets, partially offset by continued reformulation pressures from a key Indian tier-1 account and US tariff he...
✓ Verified against BSE filing
Galaxy Surfactants reported Q3 FY26 EBITDA of ₹124 crore, up 13% YoY, driven by strong specialty volume growth in India (+35%) and rest-of-world markets, partially offset by continued reformulation pressures from a key Indian tier-1 account and US tariff headwinds. EBITDA per metric ton improved to ₹20,156 from ₹17,527 last year, aided by cost efficiencies and a favorable mix shift toward high-margin prestige specialties. India performance actives declined ~4% due to reformulation, while the specialty segment grew >35%. The US reciprocal tariff reduction from 50% to 18% is a major structural positive, expected to revive pipeline projects from late Q4. However, fatty alcohol prices remain elevated, and the Egypt/AMET region saw high-teens volume decline due to competitive intensity. Management expects gradual recovery in India with new formulations commercializing in Q4, but near-term visibility remains limited. Key risk: sustained high fatty alcohol prices could prolong reformulation and delay volume recovery.
Sustained high fatty alcohol prices
View Risks →Full transcript text is available on this route.
Read Transcript →Specialty segment in India grew over 35% year-on-year, offsetting weakness in performance actives.
AMET region volumes declined in high teens due to market share losses and competitive intensity.
EBITDA per ton improved to ₹20,156 from ₹17,527, driven by mix and cost efficiencies.
Reciprocal US tariff on Indian exports reduced from 50% to 18%, restoring competitiveness.
Management expects double-digit volume growth in the specialty segment in India, supported by new product launches and customer approvals.
Fatty alcohol prices remain elevated, prolonging reformulation pressures and delaying volume recovery in India.
View Risks →